Your browser doesn't support javascript.
loading
Topical ophthalmic use of cyclosporin A for Splendore-Hoeppli phenomenon.
McGrath, Lindsay A; Whitehead, Kevin; Lee, Graham A.
Affiliation
  • McGrath LA; City Eye Centre, Brisbane, Queensland, Australia; University of Queensland, Brisbane, Queensland, Australia.
Clin Exp Optom ; 97(2): 184-6, 2014 Mar.
Article in En | MEDLINE | ID: mdl-23800332
ABSTRACT
The Splendore-Hoeppli reaction is a rare phenomenon characterised by the formation of eosinophilic material around infectious or non-infectious agents. A 33-year-old patient with persistent Splendore-Hoeppli phenomenon was previously treated with topical steroids but this resulted in a rise in intraocular pressure. The patient was treated with topical cyclosporin A one per cent twice daily as an alternative immunosuppression. After three weeks of treatment the patient had complete resolution of her conjunctival granuloma. This case report introduces cyclosporin A as a treatment option for the Splendore-Hoeppli phenomenon. This is a safe drug for long-term topical use in this condition.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eosinophilic Granuloma / Cyclosporine / Conjunctival Diseases / Immunosuppressive Agents Limits: Adult / Female / Humans Language: En Journal: Clin Exp Optom Journal subject: OPTOMETRIA Year: 2014 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eosinophilic Granuloma / Cyclosporine / Conjunctival Diseases / Immunosuppressive Agents Limits: Adult / Female / Humans Language: En Journal: Clin Exp Optom Journal subject: OPTOMETRIA Year: 2014 Document type: Article Affiliation country: Australia